Antiviral Drugs Market Analysis

  • Report ID: 473
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Antiviral Drugs Market Analysis

Drug Class - (DNA Polymerase, Reverse Transcription, Protease, Neuraminidase Inhibitors)

The global antiviral drugs market is segmented and analyzed for demand and supply by drug class into DNA polymerasesreverse transcription, protease, and neuraminidase inhibitors. Out of these, reverse transcription is anticipated to hold the largest market size by the end of 2033 on the back of the growing diagnosis and treatment rate of HIV infection and the increasing efficiency of antiviral drugs on viral diseases. In 2021, about 29 million individuals who suffered from HIV received antiretroviral therapy.

Major Macro-Economic Indicators Impacting the Market Growth

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5,355.79, which grew from USD 3,515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in the upcoming years.

Our in-depth analysis of the global market includes the following segments:


               By Drug Class

  • DNA Polymerase Inhibitors
  • Reverse Transcription Inhibitors
  • Protease Inhibitors
  • Neuraminidase Inhibitors



             By Indication

  • Influenza
  • HIV
  • AIDS
  • Hepatitis
  • Herpes Simplex Virus (HSV)
  • Coronavirus Infection

             By Type

  • Branded
  • Generic


             By Age Group

  • Pediatric
  • Adult
  • Geriatric
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar

  • Report ID: 473
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of HIV, AIDS, Hepatitis, and STDs among adults are the major factors driving the growth of the antiviral drugs market.

The market is anticipated to attain a CAGR of ~4% over the forecast period, i.e., 2023-2033.

Rising awareness about preventive drug treatment and drug resistance are the challenges affecting the market growth.

The market in North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are F. Hoffmann-La Roche Ltd, GlaxoSmithKline, Plc, Bristol Myers Squibb Company, Abbott Laboratories, Plough Publishing House, Merck & Co., Inc, Johnson & Johnson Services, Inc, AbbVie Inc., Cipla Inc., Dr Reddy’s Laboratories Ltd.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by drug class, indication, type, age group, and by region.

The reverse transcriptase segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying